|
74 Companies |
|
57 Products |
|
57 Products |
|
42 Mechanisms of Action |
|
2 Trials |
|
680 News |
|
| «12345678910111213...1314» |
- |||| CLS003 / Maruho
Trial completion, P2 data: A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. (clinicaltrials.gov) - Sep 3, 2015
P2, N=81, Completed, Sponsor: Cutanea Life Sciences, Inc.
Active, not recruiting --> Completed
- | acyclovir / Generic mfg.
Trial initiation date, Trial primary completion date: Antiviral Prophylaxis in a Burn Population (clinicaltrials.gov) - Aug 31, 2015
P2/3, N=250, Not yet recruiting, Sponsor: Southern Illinois University
Active, not recruiting --> Completed Initiation date: Jan 2015 --> Sep 2015 | Trial primary completion date: Dec 2018 --> Sep 2018
- Trial primary completion date: Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Aug 25, 2015
P1, N=39, Active, not recruiting, Sponsor: IDRI
Initiation date: Jan 2015 --> Sep 2015 | Trial primary completion date: Dec 2018 --> Sep 2018 Trial primary completion date: Jun 2015 --> Dec 2015
- Decadron (dexamethasone) / Merck (MSD)
Trial primary completion date: Use of Corticosteroids in Children With Cellulitis (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=124, Recruiting, Sponsor: Hospital General de Ni
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: May 2015 --> Dec 2015
- || tigecycline / Generic mfg.
Phase classification, Trial primary completion date: TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=100, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: May 2015 --> Dec 2015 Trial primary completion date: Dec 2020 --> Jan 2017 | Phase classification: P4 --> PN/A
- Trial primary completion date: Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=2600, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Dec 2020 --> Jan 2017 | Phase classification: P4 --> PN/A Trial primary completion date: Apr 2015 --> Dec 2015
- Trial primary completion date, IO biomarker: Interferon Responses in Eczema Herpeticum (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=120, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Apr 2015 --> Dec 2015 Trial primary completion date: Apr 2015 --> Dec 2015
- Trial completion: A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Aug 11, 2015
P2/3, N=21, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
Trial primary completion date: Apr 2015 --> Dec 2015 Recruiting --> Completed
- flucloxacillin sodium / Generic mfg.
Enrollment change: DANCE: Duration of ANtibiotic Therapy for CEllulitis (clinicaltrials.gov) - Aug 11, 2015
P4, N=316, Recruiting, Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting --> Completed N=396 --> 316
- ||||||| Zeven (dalbavancin) / RaQualia, AbbVie
Trial completion: Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (clinicaltrials.gov) - Aug 11, 2015
P3, N=698, Completed, Sponsor: Durata Therapeutics, Inc.
N=396 --> 316 Active, not recruiting --> Completed
- Humira (adalimumab) / Eisai, AbbVie
Trial primary completion date: PIONEER (OLE): Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa (clinicaltrials.gov) - Jul 14, 2015
P3, N=540, Active, not recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Active, not recruiting --> Completed Trial primary completion date: Jul 2015 --> Mar 2016
- Enrollment change: A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum (clinicaltrials.gov) - Jul 13, 2015
P2, N=60, Not yet recruiting, Sponsor: ViroXis Corporation
Trial primary completion date: Jul 2015 --> Mar 2016 N=200 --> 60
- Enrollment closed: Protocol TARC-ABPA (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Nantes University Hospital
N=200 --> 60 Recruiting --> Active, not recruiting
- Trial initiation date, Trial primary completion date: A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum (clinicaltrials.gov) - Jul 8, 2015
P2, N=200, Not yet recruiting, Sponsor: ViroXis Corporation
Recruiting --> Active, not recruiting Initiation date: Jan 2015 --> Sep 2015 | Trial primary completion date: Aug 2015 --> Aug 2016
- | HSV vaccine (GEN-003) / Genocea, Shionogi
Enrollment closed, Trial primary completion date: Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study (clinicaltrials.gov) - Jul 2, 2015
P2, N=45, Active, not recruiting, Sponsor: Genocea Biosciences, Inc.
Initiation date: Jan 2015 --> Sep 2015 | Trial primary completion date: Aug 2015 --> Aug 2016 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jun 2015 --> May 2016
- Trial completion, Enrollment change: Culture Media for Borrelia Burgdorferi Sensu Lato (clinicaltrials.gov) - Jun 30, 2015
P=N/A, N=235, Completed, Sponsor: University Medical Centre Ljubljana
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jun 2015 --> May 2016 Recruiting --> Completed | N=150 --> 235
- Trial completion, Enrollment change: AENEAS: Application of an Electronic Nose in the Early Detection of ASpergillosis (clinicaltrials.gov) - Jun 24, 2015
P=N/A, N=52, Completed, Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting --> Completed | N=150 --> 235 Recruiting --> Completed | N=150 --> 52
- | Enrollment closed, Trial primary completion date: Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis (clinicaltrials.gov) - Jun 20, 2015
P3, N=264, Active, not recruiting, Sponsor: Oswaldo Cruz Foundation
Recruiting --> Completed | N=150 --> 52 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2013 --> Dec 2015
- || Trial primary completion date: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Jun 16, 2015
P=N/A, N=106380, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2013 --> Dec 2015 Trial primary completion date: Apr 2015 --> Dec 2014
- || Naftin (naftifine hydrochloride) / Merz Pharma
Trial primary completion date: Pediatric Subjects With Tinea Corporis (clinicaltrials.gov) - Jun 11, 2015
P4, N=318, Recruiting, Sponsor: Merz Pharmaceuticals, LLC
Trial primary completion date: Apr 2015 --> Dec 2014 Trial primary completion date: May 2015 --> Aug 2015
- valacyclovir / Generic mfg.
Trial primary completion date: Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia (clinicaltrials.gov) - Jun 11, 2015
P4, N=156, Enrolling by invitation, Sponsor: University of Pittsburgh
Trial primary completion date: May 2015 --> Aug 2015 Trial primary completion date: Feb 2015 --> Nov 2015
- Tembexa (brincidofovir oral) / SymBio Pharma
Trial initiation date: A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease) (clinicaltrials.gov) - Jun 11, 2015
P1/2, N=32, Not yet recruiting, Sponsor: University of Alabama at Birmingham
Trial primary completion date: Feb 2015 --> Nov 2015 Initiation date: Dec 2014 --> Jun 2015
- Trial completion, Phase classification, Trial initiation date, Trial primary completion date: Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis (clinicaltrials.gov) - Jun 9, 2015
P2, N=40, Completed, Sponsor: Brasilia University Hospital
Initiation date: Dec 2014 --> Jun 2015 Recruiting --> Completed | Phase classification: P3 --> P2 | Initiation date: Jan 2010 --> Jul 2009 | Trial primary completion date: Jul 2011 --> Jun 2013
- ||||| Amenalief (amenamevir) / Maruho
Enrollment closed: Open-label Study of ASP2151 in Herpes Simplex Patients (clinicaltrials.gov) - Jun 6, 2015
P3, N=250, Active, not recruiting, Sponsor: Maruho Co., Ltd.
Recruiting --> Completed | Phase classification: P3 --> P2 | Initiation date: Jan 2010 --> Jul 2009 | Trial primary completion date: Jul 2011 --> Jun 2013 Recruiting --> Active, not recruiting
- Trial completion: LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine (clinicaltrials.gov) - Jun 6, 2015
P1, N=48, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change, Trial withdrawal: ToPICL: Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections (clinicaltrials.gov) - May 29, 2015
P=N/A, N=0, Withdrawn, Sponsor: Fraser Health
Active, not recruiting --> Completed N=140 --> 0 | Terminated --> Withdrawn
- Trial completion, Enrollment change: Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients (clinicaltrials.gov) - May 29, 2015
P=N/A, N=85, Completed, Sponsor: Universit
N=140 --> 0 | Terminated --> Withdrawn Recruiting --> Completed | N=60 --> 85
- Kineret (anakinra) / SOBI
Trial completion, Trial primary completion date: Anakinra in Hidradenitis Suppurativa (clinicaltrials.gov) - May 27, 2015
P2, N=20, Completed, Sponsor: University of Athens
Recruiting --> Completed | N=60 --> 85 Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Feb 2014
- |||| brilacidin (PMX-30063) / Innovation Pharma
Trial completion: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections (clinicaltrials.gov) - May 20, 2015
P2, N=215, Completed, Sponsor: Cellceutix Corporation
Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Feb 2014 Active, not recruiting --> Completed
- ||| tigecycline / Generic mfg.
Enrollment closed: TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) - May 7, 2015
P4, N=100, Active, not recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- ||| CLS003 / Maruho
Enrollment closed, P2 data: A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. (clinicaltrials.gov) - May 5, 2015
P2, N=80, Active, not recruiting, Sponsor: Cutanea Life Sciences, Inc.
Enrolling by invitation --> Active, not recruiting Recruiting --> Active, not recruiting
- |||| Baxdela (delafloxacin) / Menarini, Melinta Therap
Trial primary completion date: Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections (clinicaltrials.gov) - May 1, 2015
P3, N=660, Recruiting, Sponsor: Melinta Therapeutics, Inc.
Recruiting --> Active, not recruiting Trial primary completion date: May 2015 --> Oct 2015
- Trial completion: Soft Tissue Ultrasound of Infections (clinicaltrials.gov) - Apr 29, 2015
P1, N=15, Completed, Sponsor: Rhode Island Hospital
Trial primary completion date: May 2015 --> Oct 2015 Recruiting --> Completed
- gentamicin sulfate / Generic mfg.
Trial primary completion date: PAGELEC: WR 279,396 for the Treatment of Cutaneous Leishmaniasis (clinicaltrials.gov) - Apr 25, 2015
P2, N=30, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed Trial primary completion date: Dec 2014 --> Sep 2017
- Decadron (dexamethasone) / Merck (MSD)
Enrollment open, Trial initiation date: Use of Corticosteroids in Children With Cellulitis (clinicaltrials.gov) - Apr 20, 2015
P=N/A, N=124, Recruiting, Sponsor: Hospital General de Niños Pedro de Elizalde
Trial primary completion date: Dec 2014 --> Sep 2017 Not yet recruiting --> Recruiting | Initiation date: Mar 2014 --> Jun 2014
- Enrollment open, Trial initiation date, Trial primary completion date: Predictors of Oral Antibiotic Treatment Failure in Emergency Department Patients With Cellulitis (clinicaltrials.gov) - Apr 17, 2015
P=N/A, N=139, Recruiting, Sponsor: Royal College of Surgeons, Ireland
Not yet recruiting --> Recruiting | Initiation date: Mar 2014 --> Jun 2014 Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Mar 2015 | Trial primary completion date: Oct 2015 --> Mar 2016
- | tenofovir vaginal gel (GS-1278 gel) / Gilead, CONRAD
Trial completion, Enrollment change: Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection (clinicaltrials.gov) - Apr 16, 2015
P3, N=2059, Completed, Sponsor: CONRAD
Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Mar 2015 | Trial primary completion date: Oct 2015 --> Mar 2016 Active, not recruiting --> Completed | N=2900 --> 2059
- Trial primary completion date: AENEASII: Exhaled Breath Analysis in the Early Detection of Aspergillosis (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=150, Recruiting, Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Active, not recruiting --> Completed | N=2900 --> 2059 Trial primary completion date: Oct 2014 --> Oct 2015
- ||||| Amenalief (amenamevir) / Maruho
Enrollment closed, Trial primary completion date: Phase III Study of ASP2151 in Herpes Simplex Patients (clinicaltrials.gov) - Apr 14, 2015
P3, N=453, Active, not recruiting, Sponsor: Maruho Co., Ltd.
Trial primary completion date: Oct 2014 --> Oct 2015 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Apr 2015
- Enrollment closed: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=1927, Active, not recruiting, Sponsor: University Hospital, Geneva
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Apr 2015 Recruiting --> Active, not recruiting
- |||| Trial completion: Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores (clinicaltrials.gov) - Apr 10, 2015
P2, N=469, Completed, Sponsor: Topical Remedy
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || Ilaris (canakinumab) / Novartis
Trial completion: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease (clinicaltrials.gov) - Apr 3, 2015
P3, N=17, Completed, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Altabax (retapamulin) / GSK, Almirall
Enrollment closed: ALTARGOPMS: ALTARGO(Retapamulin) PMS(Post-marketing Surveillance) (clinicaltrials.gov) - Mar 25, 2015
P=N/A, N=3000, Active, not recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia (clinicaltrials.gov) - Mar 24, 2015
P2, N=32, Completed, Sponsor: Fundaci
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Cubicin (daptomycin) / Merck (MSD)
Trial completion: The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin (clinicaltrials.gov) - Mar 20, 2015
P4, N=20, Completed, Sponsor: Hospital Universitario Evangelico de Curitiba
Active, not recruiting --> Completed Not yet recruiting --> Completed
- |||| Cubicin (daptomycin) / Merck (MSD)
Trial completion, Gram positive: Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections (clinicaltrials.gov) - Mar 20, 2015
P4, N=396, Completed, Sponsor: Cubist Pharmaceuticals
Not yet recruiting --> Completed Suspended --> Completed
- Enrollment open: LASER-1: Laser Therapy for Onychomycosis in Patients Wih Diabetes at Risk for Diabetic Foot Complications (clinicaltrials.gov) - Mar 17, 2015
P=N/A, N=64, Recruiting, Sponsor: Medical Research Foundation, The Netherlands
Suspended --> Completed Not yet recruiting --> Recruiting
- ||| VCL-HB01 / Brickell
Enrollment closed: Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults (clinicaltrials.gov) - Mar 12, 2015
P1/2, N=156, Active, not recruiting, Sponsor: Vical
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | Trial completion: Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment (clinicaltrials.gov) - Mar 11, 2015
P1/2, N=30, Completed, Sponsor: Chulalongkorn University
Recruiting --> Active, not recruiting Recruiting --> Completed
- |||| Xepi (ozenoxacin) / Maruho, Cipher, Ferrer International
Trial primary completion date: Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo (clinicaltrials.gov) - Mar 7, 2015
P3, N=412, Recruiting, Sponsor: Ferrer Internacional S.A.
Recruiting --> Completed Trial primary completion date: Jan 2015 --> Apr 2015